The paper is part of a collaborative research organized by the International Association of Youth and Family Judges and Magistrates (AIMJF/IAYFJM) on child participation as victims or witnesses in criminal cases. The article explains the legal, institutional and procedural aspects of child participation in the Justice System in East Timor
The paper is part of a collaborative research organized by the International Association of Youth and Family Judges and Magistrates (AIMJF/IAYFJM) on child participation as victims or witnesses in criminal cases. The article explains the legal, institutional and procedural aspects of child participation in the Justice System in Cabo Verde.
This study aims to investigate the understandings by child protection practitioners regarding participation rights of the children and the challenges they encounter when promoting child participation for children in out-of-home placement. Child participation holds increasing significance within the field of child protection services in Sweden. In accordance with Article 12 of the UN Convention on the Rights of the Child, which is enshrined in Swedish law, children have the right to express their opinions on matters directly affecting them. However, child protection practitioners in Sweden have not consistently prioritized listening to children in such cases. There is limited knowledge regarding the challenges faced by child protection practitioners in promoting child participation, particularly in the context of out-of-home care. To address this research area, a qualitative systematic review was conducted, involving PRISMA statement and literature published between 1989 and 2023. Sources of documents were Scopus database, Gothenburg university catalogue and google scholar. Thematic analysis was used to showcase the results from the existing literature. Total 10 documents were included for systematic review. The results revealed that child protection practitioners hold satisfactory knowledge about child participation though still gaps of knowledge exists among them regarding UNCRC which is now law in Sweden. The study also explores the dynamics of communication between children and practitioners. Existing laws and practices as well as organizational policies define the challenges of practitioners in promoting child participation. However, other challenges e.g., perspectives and organizational challenges arose because of unsatisfactory knowledge of child participation within child participation models aligned with UNCRC but child as agent versus subject to protection also build the present perspectives towards child participation in out-of-home care. Recommendations for further research are also made based on the results and discussion of the research.
The paper is part of a collaborative research organized by the International Association of Youth and Family Judges and Magistrates (AIMJF/IAYFJM) on child participation as victims or witnesses in criminal cases. The article explains the legal, institutional and procedural aspects of child participation in the Justice System in Bosnia and Herzegovina.
The paper is part of a collaborative research organized by the International Association of Youth and Family Judges and Magistrates (AIMJF/IAYFJM) on child participation as victims or witnesses in criminal cases. The article explains the legal, institutional and procedural aspects of child participation in the Justice System in Czech Republic.
udfordringer, der er forbundet med adgang til sagsbehandleren og deling af information, kontrol og indflydelse samt forskellige former for nærhed og distance, der er opstået i kølvandet på digitaliseringen af socialt arbejde.
The paper is part of a collaborative research organized by the International Association of Youth and Family Judges and Magistrates (AIMJF/IAYFJM) on child participation as victims or witnesses in criminal cases. The article explains the legal, institutional and procedural aspects of child participation in the Justice System in England and Wales.
This paper presents the design and implementation of DLMA_NEU, adigital literacy mobile application for Android that targets children between ages 7 and 18. It is a developmental study aimed at designing a digital literacy mobile application the study conducted in the following three phases: Phase 1. Literature review; mobile application store search, and interviewing experts in children’s digital literacy, Phase 2 Smart phones app development and Phase 3 Accessing the functionality and usability of the app. Thirty students from Near East College and 5 experts were used throughout the research process. The App is the first digital literacy mobile application in Turkish.DLMA_NEUemploys children’s opinions and also adds the interactive option. To use the application, a child is required to register first.And to provide representation, the application currently supports two languages (English and Turkish). The application supports chatting with friends, and educates children (via videos, text, cartoons and jokes) on how to interact online. The application also serves as an avenue for children to report cyber bullying and other online issues as well assimultaneously acquiring informationon internet usage habits. DMLA_NEU is currently at the testing stage by children from TRCN.
Muhammad Bello Nawaila, Sezer Kanbul, Umar Mohammed Kani et al.
Aim To systematically compare the efficacy and safety of subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) in children with allergic rhinitis (AR). Methods PubMed, Embase, Cochrane Library, and Web of Science were searched from inception to March 2, 2023. Outcomes included symptom scores (SSs), medication scores (MSs), symptom and medication scores (SMSs), new sensitizations, development of asthma, improvement, and treatment-related adverse events (TRAEs). The quality of the included studies was assessed by the modified Jadad scale and Newcastle-Ottawa scale (NOS). Meta-regression was carried out to explore the source of heterogeneity. Subgroup analysis was further conducted in terms of study design [randomized controlled trials (RCTs), cohort studies], allergen [house dust mites (HDMs), grass pollen], treatment duration (≥ 24, 12-23 or < 12 months), allergen immunotherapy (AIT) modality (drops or tablets), and AIT protocol [continuous, pre-seasonal, co-seasonal, or after the grass pollen season (GPS)]. Sensitivity analysis was conducted for all outcomes. A Bayesian framework and a Monte Carlo Markov Chain (MCMC) model were developed for indirect comparison. Results Totally 50 studies with 10813 AR children were included, with 4122 treated with SLIT, 1852 treated with SCIT, and 4839 treated with non-SLIT or non-SCIT therapy. For direct comparison, the SLIT group had a similar SS to the SCIT group [pooled standardized mean difference (SMD): 0.41, 95% confidence interval (CI): -0.46, 1.28, P = 0.353]. Comparable MSs were observed in the SLIT and SCIT groups (pooled SMD: 0.82, 95%CI: -0.88, 2.53, P = 0.344). For indirect comparison, no significant differences were found in SSs (pooled SMD: 1.20, 95% credibility interval (CrI): -1.70, 4.10), MSs (pooled SMD: 0.57, 95%CrI: -1.20, 2.30), SMSs (pooled SMD: 1.80, 95%CrI: -0.005, 3.60), new sensitizations [pooled relative risk (RR): 0.34, 95%CrI: 0.03, 3.58], and development of asthma (pooled RR: 0.68, 95%CrI: 0.01, 26.33) between the SLIT and SCIT groups; the SLIT group illustrated a significantly lower incidence of TRAEs than the SCIT group (pooled RR: 0.17, 95%CrI: 0.11, 0.26). Conclusion Considering both efficacy and safety, SLIT might be a more favorable AIT than SCIT in the treatment of pediatric AR, which may serve as a decision-making reference for clinicians. Systematic review registration PROSPERO (CRD42023460693).
INTRODUCTION: Medical devices (MedDevs) and medicines are assessed (and monitored) differently before and after launch. There are products for repeated oral ingestion that are marketed in the European Union as MedDevs. OBJECTIVES AND METHODS: To illustrate the consequences of these differences in assessment, we compared the leaflet information of three MedDevs with the standards for medicines and with published evidence at launch. As examples, gelatin tannate (GT), its combination with tyndalised probiotics (TP) (GTTP) for diarrhoea and a gel containing hyaluronic acid (HA)/chondroitin sulfate (CS)/poloxamer (Pol407) (HACSPol) for gastro-oesophageal reflux disease were examined. RESULTS: Applying standards for medicines, product composition is insufficiently defined in the MedDev leaflet (eg, plant origin, polymerisation grade, dose and ratio of the relevant constituents). As no age limit is mentioned in the leaflets, all 3 products allow use in children from birth onwards, although published clinical documentation in children was poor (GT) or lacking (GTTP and HACSPol). MedDev leaflets do not mention adverse events (AEs), while literature search suggests safety concerns such as tannic acid (TA) cytotoxicity, potentially more diarrhoea/AEs with TP, use of doses higher than established safe (TA and HA) and lack of chronic toxicity studies for oral Pol407. None refers to interactions with medicines, although some ingredients may affect medicine absorption. CONCLUSION: Although these MedDevs require repeated oral intake as do medicines, their assessment and monitoring differ significantly from the standards for medicines. Compared with medicines, MedDevs for repeated oral use are poorly labelled and rely on very limited clinical information at market release.
Suzy Huijghebaert, Pauline De Bruyne, Karel Allegaert et al.